ANDOVER, Mass., June 15, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc . (NASDAQ: MKSI “MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced that it is celebrating the 60 th anniversary of the founding of the company. John T.C. Read more
Data for EVRYSDI reinforce safety profile and efficacy in a broad spinal muscular atrophy (SMA) population, following recent EU approval Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) build on safety profile and efficacy following recent CHMP opinion, including in adults with concomitant autoimmune diseases (CAIDs) OCREVUS data continue to show consistent benefit on... Read more
Polymerization reactions are involved in many industrial processes and also occur in everyday tasks, for example during the hardening of glues and drying of paints and varnishes. In order to optimize their products, manufacturers require analytical methods for monitoring polymerization reactions and evaluating the influence of chemical modifications or additives such as catalysts. Here we... Read more
Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021 Enhanced solution delivers balance of speed and quality to accelerate and expedite DNA to Investigational New Drug in as little as 13 months WALTHAM, Mass., June 14, 2021 /PRNewswire/ — BIO DIGITAL 2021 – New... Read more
MENLO PARK, Calif., June 11, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock,... Read more
CHICAGO – June 11, 2021 – At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare is proud to showcase new molecular imaging products and solutions as well as new opportunities to expand access to radioactive tracers and other pharmaceutical imaging agents. This increase in access to the latest and... Read more
CHICAGO – June 11, 2021 – At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare is proud to showcase new molecular imaging products and solutions as well as new opportunities to expand access to radioactive tracers and other pharmaceutical imaging agents. This increase in access to the latest and... Read more
Four-year follow-up analysis from the phase III CLL14 study showed progression-free survival rate of 74.0% in previously untreated patients with chronic lymphocytic leukaemia (CLL) three years after completion of a one-year fixed-duration treatment with Venclexta/Venclyxto plus Gazyva/Gazyvaro1 New phase III MURANO study data suggested certain genetic risk factors may help tailor treatments for patients with... Read more
Data from JEWELFISH, the first trial in a diverse population aged 1 to 60 years with SMA who received prior treatment, showed a consistent safety profile and >2-fold increase in SMN protein levels Pre-symptomatic babies with SMA treated with Evrysdi for at least one year were able to sit, stand and walk in preliminary data... Read more
June 10, 2021 at 8:01 AM EDTPDF Version Fueling Discovery in Preserved Tissue Samples to Advance Clinical Translational Research PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the... Read more